Physician

Abigail Faith Veldkamp, O.D.

According to 2025 Medicare claims, Abigail Veldkamp, O.D. (NPI: 1851647218) practices optometrist in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is BLUE SKY VISION EYE CARE, P.C (NPI: 1801977202; TIN: 38-2394920) and primary practice location at 49418-2368.

Veldkamp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 146 traditional Medicare patients, billed 282 HCPCS/CPT codes, and received $15,995 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 366 prescription claims across 150 beneficiaries totaling $68,732 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 8 records totaling $276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,397 to $68,732. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$11K$23K2015 Medicare payment: $15,696 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $17,658 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $20,079 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $22,400 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $22,858 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $16,496 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $20,669 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $20,137 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $19,761 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $15,995 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015182227$15,696
2016212284$17,658
2017200311$20,079
2018213397$22,400
2019197409$22,858
2020158313$16,496
2021172351$20,669
2022178339$20,137
2023160342$19,761
2024146282$15,995

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$34K$69K2015 Drug cost: $7,397 (USD; Tot_Drug_Cst)2016 Drug cost: $9,442 (USD; Tot_Drug_Cst)2017 Drug cost: $14,455 (USD; Tot_Drug_Cst)2018 Drug cost: $22,950 (USD; Tot_Drug_Cst)2019 Drug cost: $30,569 (USD; Tot_Drug_Cst)2020 Drug cost: $31,072 (USD; Tot_Drug_Cst)2021 Drug cost: $40,850 (USD; Tot_Drug_Cst)2022 Drug cost: $43,974 (USD; Tot_Drug_Cst)2023 Drug cost: $49,662 (USD; Tot_Drug_Cst)2024 Drug cost: $68,732 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153460$7,397
20163672$9,442
20174377$14,455
201885207$22,950
201979254$30,569
202082234$31,072
2021135303$40,850
2022142331$43,974
2023147370$49,662
2024150366$68,732

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system1616$85
92014Established patient complete exam of visual system6971$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4759$57
92060Exam to measure eye deviation and range of motion5462$42
92134Imaging of retina2526$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine272,010$38,741
SimbrinzaBrinzolamide/Brimonidine Tart15444$3,099
LatanoprostLatanoprost1036,096$1,793
Brimonidine TartrateBrimonidine Tartrate351,090$1,622
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha591,111$814

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$276ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abigail Faith Veldkamp, O.D.?

Tedicare shows public-source Medicare data for Abigail Faith Veldkamp, O.D. (NPI 1851647218), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail Faith Veldkamp, O.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abigail Faith Veldkamp, O.D.?

Abigail Faith Veldkamp, O.D. is linked to BLUE SKY VISION EYE CARE, P.C (billing NPI 1801977202) in the available physician profile data.

Does Abigail Faith Veldkamp, O.D. have Open Payments data?

Abigail Faith Veldkamp, O.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.